Ming‐Jin Xie

1.4k total citations
85 papers, 1.2k citations indexed

About

Ming‐Jin Xie is a scholar working on Inorganic Chemistry, Oncology and Organic Chemistry. According to data from OpenAlex, Ming‐Jin Xie has authored 85 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Inorganic Chemistry, 41 papers in Oncology and 26 papers in Organic Chemistry. Recurrent topics in Ming‐Jin Xie's work include Metal complexes synthesis and properties (38 papers), Magnetism in coordination complexes (23 papers) and Metal-Organic Frameworks: Synthesis and Applications (17 papers). Ming‐Jin Xie is often cited by papers focused on Metal complexes synthesis and properties (38 papers), Magnetism in coordination complexes (23 papers) and Metal-Organic Frameworks: Synthesis and Applications (17 papers). Ming‐Jin Xie collaborates with scholars based in China, Malaysia and Germany. Ming‐Jin Xie's co-authors include Weiping Liu, Sheng‐Hong Li, Ling Li, Shi‐Hong Luo, Qi‐Hua Zhao, Shi‐Ping Yan, Xue‐Mei Niu, Lihui Gao, Yanfen Niu and Zhaohui Meng and has published in prestigious journals such as Angewandte Chemie International Edition, Advanced Functional Materials and Chemical Communications.

In The Last Decade

Ming‐Jin Xie

82 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming‐Jin Xie China 21 413 391 386 307 195 85 1.2k
Ján Vančo Czechia 24 428 1.0× 453 1.2× 915 2.4× 1.1k 3.5× 303 1.6× 91 1.9k
Laura Santagostini Italy 22 644 1.6× 298 0.8× 294 0.8× 485 1.6× 288 1.5× 55 1.5k
Yuyuan Xie China 19 123 0.3× 378 1.0× 558 1.4× 181 0.6× 98 0.5× 80 1.1k
Maria Fátima Lucas Spain 23 173 0.4× 653 1.7× 292 0.8× 282 0.9× 225 1.2× 47 1.4k
Jichun Cui China 20 285 0.7× 192 0.5× 605 1.6× 294 1.0× 193 1.0× 56 1.0k
Wolf‐D. Woggon Switzerland 22 601 1.5× 576 1.5× 795 2.1× 127 0.4× 309 1.6× 56 1.6k
Ying Dong Canada 24 125 0.3× 301 0.8× 704 1.8× 118 0.4× 88 0.5× 57 1.4k
Paul Mosset France 21 147 0.4× 390 1.0× 716 1.9× 72 0.2× 249 1.3× 82 1.3k
R. Ramu India 23 251 0.6× 546 1.4× 928 2.4× 88 0.3× 177 0.9× 51 1.5k
Hanna Lewandowska Poland 15 104 0.3× 224 0.6× 264 0.7× 140 0.5× 145 0.7× 39 1.1k

Countries citing papers authored by Ming‐Jin Xie

Since Specialization
Citations

This map shows the geographic impact of Ming‐Jin Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Jin Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Jin Xie more than expected).

Fields of papers citing papers by Ming‐Jin Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Jin Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Jin Xie. The network helps show where Ming‐Jin Xie may publish in the future.

Co-authorship network of co-authors of Ming‐Jin Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Jin Xie. A scholar is included among the top collaborators of Ming‐Jin Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Jin Xie. Ming‐Jin Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Zhou, Sihan, Wenhui Liao, Wei Li, et al.. (2023). (8-Hydroxyquinoline) Gallium(III) Complex with High Antineoplastic Efficacy for Treating Colon Cancer via Multiple Mechanisms. ACS Omega. 8(7). 6945–6958. 15 indexed citations
5.
Wu, Yuanyuan, Wenhui Liao, Sihan Zhou, et al.. (2023). Gallium Metal−Organic Nanoparticles with Albumin-Stabilized and Loaded Graphene for Enhanced Delivery to HCT116 Cells. International Journal of Nanomedicine. Volume 18. 225–241. 3 indexed citations
6.
Liao, Wenhui, Xueqing Song, Yanjie Kong, et al.. (2021). A novel Schiff base cobalt(III) complex induces a synergistic effect on cervical cancer cells by arresting early apoptosis stage. BioMetals. 34(2). 277–289. 9 indexed citations
7.
Xu, Yuan, Qingyi Yang, Tongyan Liu, et al.. (2019). Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase. European Journal of Medicinal Chemistry. 179. 147–165. 66 indexed citations
8.
Zhao, Yongqiang, Fei‐Fei Liu, Ke Li, et al.. (2019). Discovery of arylamide-5-anilinoquinazoline-8-nitro derivatives as VEGFR-2 kinase inhibitors: Synthesis, in vitro biological evaluation and molecular docking. Bioorganic & Medicinal Chemistry Letters. 29(23). 126711–126711. 21 indexed citations
9.
Xie, Ming‐Jin, Yi Jin, Lihui Gao, et al.. (2017). Synthesis and characterization of oxidovanadium complexes as enzyme inhibitors targeting dipeptidyl peptidase IV. Journal of Inorganic Biochemistry. 175. 29–35. 14 indexed citations
11.
Huang, Kun, et al.. (2011). Synthesis of spirocyclic β-keto-lactams: copper catalyzed process. Chemical Communications. 47(17). 4923–4923. 22 indexed citations
12.
Xie, Ming‐Jin, Ling Li, Xiaoda Yang, et al.. (2010). A new insulin-enhancing agent: [N,N′-bis(4-hydroxysalicylidene)-o-phenylene-diamine]oxovanadium(IV) and its permeability and cytotoxicity. European Journal of Medicinal Chemistry. 45(6). 2327–2335. 21 indexed citations
13.
Xie, Ming‐Jin, Xiaoda Yang, Weiping Liu, Shi‐Ping Yan, & Zhaohui Meng. (2010). Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity. Journal of Inorganic Biochemistry. 104(8). 851–857. 52 indexed citations
14.
Xie, Ming‐Jin, Yanfen Niu, Xiaoda Yang, et al.. (2010). Effect of the chloro-substitution on lowering diabetic hyperglycemia of vanadium complexes with their permeability and cytotoxicity. European Journal of Medicinal Chemistry. 45(12). 6077–6084. 34 indexed citations
15.
Zhao, Qi‐Hua, et al.. (2009). Tris[2-(2-pyridyliminomethyl)phenolato(0.67−)]europium(III) nitrate. Acta Crystallographica Section E Structure Reports Online. 65(6). m697–m697. 1 indexed citations
16.
Niu, Yanfen, et al.. (2008). Bis(<I>α</I>-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes. Journal of Pharmacy and Pharmacology. 60(10). 1335–1340. 4 indexed citations
17.
Liu, Weiping, et al.. (2008). Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-κ2N,N′] platinum(II) complexes. Journal of Inorganic Biochemistry. 102(10). 1942–1946. 23 indexed citations
18.
Gao, Lihui, Yanfen Niu, Weiping Liu, et al.. (2007). The antilipolytic action of bis(α-furancarboxylato)oxovanadium(IV) in adipocytes. Clinica Chimica Acta. 388(1-2). 89–94. 10 indexed citations
19.
Niu, Yanfen, Weiping Liu, Ming‐Jin Xie, et al.. (2007). Effects of bis(α-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats. European Journal of Pharmacology. 572(2-3). 213–219. 22 indexed citations
20.
Xie, Ming‐Jin, et al.. (2007). In vivo insulin-mimetic activity of [N,N′-1,3-propyl-bis(salicyladimine)]oxovanadium(IV). European Journal of Medicinal Chemistry. 42(6). 817–822. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026